Total Payments
$10,056
2024 Payments
$1,334
Companies
62
Transactions
377
Medicare Patients
4,625
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$7,156 (71.2%)
Consulting$2,900 (28.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,156 | 376 | 71.2% |
| Consulting Fee | $2,900 | 1 | 28.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,381 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $655.84 | 42 | $0 (2024) |
| Janssen Biotech, Inc. | $468.92 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $461.27 | 24 | $0 (2024) |
| Amgen Inc. | $459.28 | 31 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $416.90 | 24 | $0 (2024) |
| Incyte Corporation | $362.26 | 14 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $344.84 | 12 | $0 (2024) |
| PFIZER INC. | $300.62 | 17 | $0 (2024) |
| Celgene Corporation | $257.38 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,334 | 59 | PFIZER INC. ($164.58) |
| 2023 | $1,580 | 65 | AstraZeneca Pharmaceuticals LP ($180.88) |
| 2022 | $738.96 | 36 | Incyte Corporation ($89.67) |
| 2020 | $3,167 | 16 | AstraZeneca Pharmaceuticals LP ($2,936) |
| 2019 | $1,387 | 85 | Novartis Pharmaceuticals Corporation ($262.14) |
| 2018 | $1,028 | 64 | Novartis Pharmaceuticals Corporation ($148.68) |
| 2017 | $821.14 | 52 | Novartis Pharmaceuticals Corporation ($136.17) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: HORMONE THERAPY | ||||||
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $28.86 | General |
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.49 | General |
| 11/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: HORMONE THERAPY | ||||||
| 10/21/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $27.05 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/17/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: HORMONE THERAPY | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Oncology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TALVEY (Biological), TECVAYLI, DARZALEX | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/03/2024 | Amneal Pharmaceuticals LLC | AVASTIN (Drug), NEULASTA, NEUPOGEN | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $28.12 | General |
| Category: Oncology | ||||||
| 08/20/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,336 | 3,934 | $4.0M | $624,429 |
| 2022 | 27 | 1,274 | 4,120 | $4.0M | $610,955 |
| 2021 | 24 | 845 | 2,913 | $3.1M | $482,371 |
| 2020 | 28 | 1,170 | 5,435 | $4.5M | $707,425 |
Total Patients
4,625
Total Services
16,402
Medicare Billing
$2.4M
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 89 | 547 | $1.4M | $150,313 | 10.6% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 85 | 436 | $230,644 | $77,861 | 33.8% |
| G6017 | Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | Office | 2023 | 89 | 522 | $391,500 | $48,220 | 12.3% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 55 | 246 | $151,782 | $44,356 | 29.2% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 77 | 477 | $275,229 | $44,003 | 16.0% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 29 | 31 | $187,953 | $43,760 | 23.3% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 116 | 248 | $249,488 | $36,593 | 14.7% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 15 | 31 | $239,909 | $23,651 | 9.9% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 67 | 222 | $148,060 | $21,311 | 14.4% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 51 | 54 | $61,074 | $18,683 | 30.6% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 43 | 46 | $189,658 | $16,801 | 8.9% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 124 | 247 | $79,781 | $16,182 | 20.3% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 72 | 292 | $100,156 | $14,751 | 14.7% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 11 | 12 | $48,000 | $14,550 | 30.3% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 29 | 31 | $77,159 | $11,100 | 14.4% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 38 | 51 | $31,263 | $10,381 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $20,646 | $7,391 | 35.8% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 53 | 54 | $52,002 | $7,063 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 65 | $14,105 | $5,823 | 41.3% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 28 | 85 | $54,145 | $4,875 | 9.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 93 | 113 | $10,735 | $4,523 | 42.1% |
| 77332 | Design and construction of simple radiation treatment device | Office | 2023 | 46 | 50 | $13,900 | $1,476 | 10.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $1,728 | $760.00 | 44.0% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2022 | 82 | 650 | $1.7M | $183,233 | 10.9% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 64 | 707 | $407,939 | $66,510 | 16.3% |
About Dr. Robert Gin, M.D
Dr. Robert Gin, M.D is a Radiation Oncology healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811966575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Gin, M.D has received a total of $10,056 in payments from pharmaceutical and medical device companies, with $1,334 received in 2024. These payments were reported across 377 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($7,156).
As a Medicare-enrolled provider, Gin has provided services to 4,625 Medicare beneficiaries, totaling 16,402 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Tucson, AZ
- Active Since 03/15/2006
- Last Updated 02/23/2024
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1811966575
Products in Payments
- TAGRISSO (Drug) $2,922
- KEYTRUDA (Biological) $448.47
- LIBTAYO (Biological) $329.75
- JAKAFI (Drug) $299.65
- ORGOVYX (Drug) $277.89
- LYNPARZA (Drug) $184.21
- KISQALI (Drug) $166.13
- DARZALEX (Biological) $157.72
- Revlimid (Drug) $153.01
- Xofigo (Drug) $145.63
- IMBRUVICA (Drug) $144.21
- INLYTA (Drug) $135.37
- Nplate (Biological) $121.03
- Perjeta (Biological) $118.46
- GILOTRIF (Drug) $116.45
- AFINITOR (Drug) $112.87
- NINLARO (Drug) $105.40
- ENHERTU (Biological) $102.57
- Nubeqa (Drug) $91.01
- Kyprolis (Biological) $90.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Tucson
Baldassarre Stea, Md, Phd, MD, PHD
Radiation Oncology — Payments: $10,070
Radiation Oncology $10,070
Curtis Mack, M.d, M.D
Radiation Oncology — Payments: $7,713
Radiation Oncology $7,713
David Vonk, Md, MD
Radiation Oncology — Payments: $4,421
Radiation Oncology $4,421
Reginald Westmacott, M.d, M.D
Radiation Oncology — Payments: $2,957
Radiation Oncology $2,957
Dolores Basden, M.d, M.D
Radiation Oncology — Payments: $2,384
Radiation Oncology $2,384
Dr. Samuel Day, Md, Phd, MD, PHD
Radiation Oncology — Payments: $2,333
Radiation Oncology $2,333